IP Library Granted Patent US 11,241,388
Granted Patent B2
US 11,241,388 · App. 16/524,591 · Granted Feb 8, 2022

Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement

Inventor: James R. Komorowski (Trumbull, CT)
Assignee: JDS Therapeutics, LLC
A61K9/209A23L33/15A61K9/00A61K9/0053A61K31/155A61K45/06A23V2002/00Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,241,388
App. No.
16/524,591
Granted
Feb 8, 2022
Kind
B2
Abstract

Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.

Claims (25)

1. A dosage form for oral administration comprising:

an inner therapeutic agent;

a middle barrier layer disposed over the therapeutic agent, wherein the therapeutic agent is selected from anxiolytics, anticonvulsants, antiemetics, hormonal contraceptives, selective estrogen receptor modulators, and fertility agents, or combinations thereof; and

an outer nutritional supplement layer disposed over the barrier layer, wherein the nutritional supplement is a vitamin, a mineral, or a combination thereof;

wherein said inner therapeutic agent and outer nutritional supplement layer are formulated as a single dose.

2. The dosage form of claim 1 , wherein the therapeutic agent further comprises one or more of analgesics, anesthetics, bronchodilators, decongestants, anti-proliferatives, antibiotics, anti-virals, chemotherapeutics, immuno-suppressants, and anti-pruritics, or combinations thereof.

3. The dosage form of claim 2 , wherein the therapeutic agent is provided in a therapeutically effective amount.

4. The dosage form of claim 1 , wherein the therapeutic agent is selected from anxiolytics, hormonal contraceptives, and fertility agents, or combinations thereof.

5. The dosage form of claim 4 , wherein the therapeutic agent is selected from hormonal contraceptives and fertility agents.

6. The dosage form of claim 5 , wherein the therapeutic agent is one or more hormonal contraceptives.

7. The dosage form of claim 5 , wherein the therapeutic agent is one or more fertility agents.

8. The dosage form of claim 1 , wherein the barrier layer is comprised of a controlled-release, delayed-release, or enteric coating.

9. The dosage form of claim 1 , wherein the nutritional supplement is provided in a therapeutically effective amount.

10. The dosage form of claim 1 , wherein the nutritional supplement is selected from the group consisting of biotin, choline, folate, niacin, pantothenic acid, riboflavin, thiamine, vitamin A, vitamin B6, vitamin B12, vitamin C, vitamin E, bromine, cobalt, copper, fluorine, germanium, iodine, iron, magnesium, manganese, molybdenum, potassium, selenium, silicon, zinc, calcium, phosphorous, sodium, sulfur, and vanadium, or combinations thereof.

11. A method of preventing and/or attenuating depletion of a nutrient caused by the co-administration of a therapeutic agent to an individual in need thereof, comprising:

identifying an individual presenting with nutrient depletion associated with the administration of a therapeutic agent; and

administering to the individual the dosage form of claim 1 , wherein said therapeutic agent causes or exacerbates nutrient depletion, wherein said nutritional supplement prevents and/or attenuates said depletion; and wherein said nutrient is selected from the group consisting of biotin, choline, folate, niacin, pantothenic acid, riboflavin, thiamine, vitamin A, vitamin B6, vitamin B12, vitamin C, vitamin E, bromine, cobalt, copper, fluorine, germanium, iodine, iron, magnesium, manganese, molybdenum, potassium, selenium, silicon, zinc, calcium, phosphorous, sodium, sulfur, and vanadium, or combinations thereof.

12. The method of claim 11 , wherein said therapeutic agent is selected from anxiolytics, anticonvulsants, antiemetics, hormonal contraceptives, selective estrogen receptor modulators, and fertility agents, or combinations thereof.

13. The method of claim 11 , wherein said therapeutic agent is selected from anxiolytics, hormonal contraceptives, and fertility agents, or combinations thereof.

14. The method of claim 11 , wherein said therapeutic agent is selected from hormonal contraceptives and fertility agents.

15. The method of claim 11 , wherein said therapeutic agent is one or more hormonal contraceptives.

16. The method of claim 11 , wherein said therapeutic agent is one or more fertility agents.

17. The method of claim 11 , wherein said nutritional supplement prevents said nutrient depletion.

18. The method of claim 11 , wherein said nutritional supplement attenuates said nutrient depletion.

19. A method of synergistically treating a disease or condition caused or exacerbated by nutrient depletion comprising administering to an individual in need thereof the dosage form of claim 1 , wherein the disease or condition is selected from cardiovascular disease, stroke, cardiovascular lesions, aterial and myocardial lesions, cardiac arrhythmias, depletion of selenium, cardiomyopathy resulting from selenium depletion, depletion of co-enzyme Q10 caused by statin drug therapy, and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2023
From: JDS THERAPEUTICS, LLC
To: BONAFIDE HEALTH, LLC
Reel/Frame 065072/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2021
From: KOMOROWSKI, JAMES R.
To: JDS THERAPEUTICS, LLC
Reel/Frame 057469/0574 →